Lipid from Infective L. donovani Regulates Acute Myeloid Cell Growth via Mitochondria Dependent MAPK Pathway

Abstract

The microbial source, which includes live, attenuated, or genetically modified microbes or their cellular component(s) or metabolites, has gained increasing significance for therapeutic intervention against several pathophysiological conditions of disease including leukemia, which remains an incurable disease till now despite recent advances in the medical sciences. We therefore took up the present study to explore if the leishmanial lipid (pLLD) isolated from L. donovani can play an anti-neoplastic role in acute myeloid leukemia cells by regulating cellular growth. Indeed pLLD significantly inhibited cell proliferation of four AML cell lines (HL-60, MOLT-4, U937, and K562). Scanning electron microscopy and DNA fragmentation analysis revealed that it significantly induced apoptosis of U937 cells through morphological alteration. Occurrence of apoptosis was checked by using Annexin exposure and this established that the cell cycle was arrested at G0/G1 phase in time-dependent manner. pLLD increased the intracellular ROS with alteration of mitochondrial membrane potential, as detected using DCFDA. It also regulated the expression of apoptosis-related proteins like Bax, Bcl2, Bad and t-Bid besides causing cleavage of PARP as determined by western blot analysis. Treatment of U937 cells with pLLD induced the activation of extracellular signal-regulated kinase (ERK)1/2, c-Jun N-terminal kinase (JNK)1/2, p38, and caspases 9/3. The results suggest that pLLD induces apoptosis in acute myeloid leukemia cells possibly via increasing intracellular ROS and regulating the MAPK pathway.

MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2

“…It was well known that Bcl2 inhibits Beclin1-dependent autophagy by interacting with the evolutionarily conserved autophagy-related protein Beclin1 in yeast and mammalian cells [27]. It was reported that the phosphorylation of ERK1/2 is associated with the high expression of Bcl2 [28]. Here, we found that TGF-β1 enhanced the expression of Bcl2 maybe through the ERK1/2 signal pathway.…”

Formononetin promotes apoptosis of colorectal cancer cells via activation of mitochondria-dependent MAPK pathway

“…MAPKs, also known as extracellular signalregulated kinases (ERKs), are highly conserved molecules regulating various extracellular and intracellular signalling pathways [9]. Three subfamilies of MAPK including ERK1/2, JNK, and p38 kinase are associated with the regulation of many physiopathological processes, such as apoptosis, differentiation, and senescence [9]. ROS acts as a common and important modulator of many cellular signalling pathways.…”

“…ROS acts as a common and important modulator of many cellular signalling pathways. It is known to activate several MAPKs, which can thus induce apoptosis in response to cellular oxidative stress [9]. Mitochondria are the main sources of ROS, generated specifically by complexes I and III of the respiratory chain.…”

“…(Figure 4). Next the possible role of the MAPK pathway was tested after formononetin treatment [9]. Formononetin significantly suppressed the phosphorylation of ERK1/2 and promoted the phosphorylation of c-Jun Nterminal kinase (JNK) and p38 in a dosedependent manner in both SW1463 and T84 cells ( Figure 7).…”

MicroRNA‑490‑3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation

“…Their functions have remained highly evolutionarily conserved (18). MAPK1, also known as ERK2, is a ~42 kD protein and is mediates one of the most important signaling pathways in vivo, with a crucial role in cell growth, differentiation, proliferation, survival and in the inflammatory response (19). A previous study reported that the MAPK1 signaling pathway is crucial in most cells and is regulated at numerous levels.…”